Epilepsy in North America a report prepared under the auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization

Epilepsia

Volumn 47, Issue 10, 2006, Pages 1700-1722

  Theodore, William H ^a,i   Spencer, Susan S ^b   Wiebe, Samuel ^c   Langfitt, John T ^d   Ali, Amza ^e   Shafer, Patricia O ^f   Berg, Anne T ^g   Vickrey, Barbara G ^h  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ROCHESTER   (United States)

^e UNIVERSITY OF THE WEST INDIES   (Jamaica)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g NORTHERN ILLINOIS UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NIH Building 10 ^*  (United States)

Author keywords

Cost; Incidence; Prevalence; Research; Seizures; Stigma; Treatment resources

Indexed keywords

ARTICLE; DISABILITY; DISEASE CLASSIFICATION; EMPLOYMENT; EPILEPSY; ETHNOLOGY; FUNDING; GENDER; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INCIDENCE; INCOME; MEDICAL RESEARCH; MORTALITY; NORTH AMERICA; OUTPATIENT CARE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RELIGION; RESOURCE ALLOCATION; SELF MEDICATION; SOCIOECONOMICS; WORLD HEALTH ORGANIZATION;

EPILEPSY; HEALTH STATUS; HUMANS; INTERNATIONAL AGENCIES; NORTH AMERICA; PREVALENCE; QUALITY OF LIFE; RESEARCH SUPPORT; RESEARCH SUPPORT AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 33749656780     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00633.x     Document Type: Article

References (128)

1. Annegers JF, Rocca WA, Wa H. (1996) Causes of epilepsy: contributions of the Rochester Epidemiology Project. Mayo Clinic Proceedings 71:570-575.
2. Annegers JF, Dubinsky S, Coan SP, Newmark ME, Roht L. (1999) The incidence of epilepsy and unprovoked seizures in a multiethnic, urban health maintenance organization. Epilepsia 40:502-506.
3. Arthritis Foundation. (1999) National Arthritis Action Plan: a public health strategy. 〈http://www.arthritis.org/resources/ ActionPlanInterior〉.
4. Asplin BR, Rhodes KV, Levy L Lurie N, Crain AL, Carlin BP, Kellermann AL. (2005) Insurance status and access to urgent ambulatory care follow-up appointments. Journal of the American Medical Association 294:1248-1254.
5. Austin JK, Shafer PO, Deering JB. (2002a) Epilepsy familiarity, knowledge and perceptions of stigma: report from a survey of adolescents in the general population. Epilepsy and Behavior 3:368-375.
6. Austin JK, Shafer PO, Deenay JB. (2002b) Epilepsy familiarity, knowledge, and perceptions of stigma: report from a survey of adolescents in the general population. Epilepsy and Behavior 3:68-75.
7. Austin JK, MacLeod J, Dunn DW, Shen J, Perkins SM. (2004) Measuring stigma in children with epilepsy and their parents: instrument development and testing. Epilepsy and Behavior 5:472-482.
8. Baker GA, Camfield C, Camfield P, Cramer JA, Elger CE, Johnson AL, Martins da Silva A, Meinardi H, Munari C, Perucca E, Thorbecke R. (1998) Commission on outcome measurement in epilepsy 1994-1997: final report. Epilepsia 39:213-231.
9. Baker GA, Brooks J, Buck D, Jacoby A. (2000) The stigma of epilepsy: a European perspective. Epilepsia 41:98-104.
10. Banks J, Marmot M, Oldfield Z, Smith JP. (2006) Disease and disadvantage in the United States and England. Journal of the American Medical Association 295:2037-2045.
11. Barton JH, Emanuel EJ. (2005) The patient-based pharmaceutical development process: rationale, problems, and potential reforms. Journal of the American Medical Association 294:2075-2082.
12. Begley CE, Famulari M, Annegers JF, Larson DR, Reynolds TF, Coan S, Dubinsky S, Newmark ME, Leibson C, So E, Rocca WA. (2000) The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 41:342-351.
13. Berg AT, Shinnar S, Shapiro ED, Salomon ME, Crain EF, Hauser WA. (1995) Risk factors for a first febrile seizure: a matched case-control study. Epilepsia 36:334-341.
14. Berg AT, Shinnar S, Levy SR, Testa FM. (1999) Newly diagnosed epilepsy in children: presentation and diagnosis. Epilepsia 40:445-452.
15. Berg AT, Testa FM, Levy SR, Shinnar S. (2000) Neuroimaging in children with newly diagnosed epilepsy: a community-based study. Pedatrics 106:527-532.
16. Berg AT, Shinnar S, Testa FM, Levy SR, Smith SN, Beckerman B. (2004) Mortality in childhood onset epilepsy. Archives of Pediatric and Adolescent Medicine 158:1147-1152.
17. Bodenheimer T, Lorig K, Holman H, Grumbach K. (2002) Patient self-management of chronic disease in primary care. Journal of the American Medical Association 288:2469-2475.
18. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelser N. (2006) Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. Journal of the American Medical Association 295:429-433.
19. Burneo JG, Black L, Knowlton RC, Faught E, Morawetz R, Kuzinecky RI. (2005) Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology 64:50-54.
20. Burris S. (2006) Stigma and the law. Lancet 367:529-531.
21. Callenbach PMC, Westendorb RGJ, Geerts AT, Arts WF Peeters EAJ, van Donselaar CA, Peters ACB, Stroink H, Brouwer OF. (2001) Mortality in children with epilepsy: the Dutch study of epilepsy in childhood. Pediatrics 107:1259-1263.
22. Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. (1996) Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia 37:19-23.
23. Camfield CS, Camfield PR, Veugelers PJ. (2002) Death in children with epilepsy: a population-based study. Lancet 43:662-663.
24. Canadian Health Coalition (2004). Briefing note. 〈http://www. healthcoalition.ca/sus-e.pdf〉.
25. Capps R, Fix ME, Ost J, Reardon-Anderson J, Passel JS. (2005) The health and well-being of young children of immigrants. Urban Institute. 〈http://www.urban.org/url.cfm?ID=311182〉.
26. Carpenter DP. (2004) The political economy of FDA drug review: processing, politics, and lessons for policy. Health Affairs 23:52-63.
27. Cassano P, Koepsell T, Farwell J. (1987) Risk factors for febrile seizures in childhood. American Journal of Epidemiology/Epilepsy 126:745.
28. Centers for Disease Control. (1994) Current trends: prevalence of self-reported epilepsy: United States 1986-1990. Morbidity and Mortality Weekly Report 43:810-811.
29. Centers for Disease Control. (1997) Health risks in America: gaining insight from the Behavioral Risk Factor Surveillance System revised. U.S. Department of Health and Human Services, Atlanta.
30. Centers for Disease Control. (1998) Health-related quality of life and activity limitation: eight states, 1995. Morbidity and Mortality Weekly Report 47:135-140.
31. Centers for Disease Control. (2001) Health related quality of life among persons with epilepsy: Texas 1998. Morbidity and Mortality Weekly Report 50:24-26.
32. Centers for Disease Control. (2005). Prevalence of epilepsy and health-related quality of life and disability among adults with epilepsy in South Carolina, 2003-2004. Morbidity and Mortality Weekly Report 54:1080-1082.
33. Centers for Disease Control. (2006) Epilepsy Programs. 〈http://www.cdc.gov/Epilepsy/program activities.htm〉.
34. Center for the Evaluative Clinical Sciences. (1998) The Dartmouth Atlas of health care. American Hospital Publishing, Hanover.
35. Christian-Herman J, Emons M, George D. (2004) Effects of generic-only drug coverage in a Medicare HMO. Health Affairs W 4:455-468.
36. Chronic Disease Directors. (2003) The role of public health in addressing lower prevalence chronic conditions: the example of epilepsy. 〈http://www.chronicdisease.org/Publicationsy.Reportsy.New/epilepsyy.report. pdf〉.
37. Collings JA. (1990) Psychosocial well-being and epilepsy: an empirical study. Epilepsia 31:418-426.
38. Congressional Budget Office. (2005) The long term budget outlook 2005. 〈http://www.cbo.gov/ftpdocs/69xx/doc6982/12-15-LongTermOutlook.pdf〉.
39. Cowan LD, Bodensteiner JB, Leviton A, Doherty L. (1989) Prevalence of the epilepsies in children and adolescents. Epilepsia 30:94-106.
40. Cramer JA, Westbrook LE, Devinsky O, Perrine K, Glassman MB, Camfield C. (1989) Development of the quality of life in epilepsy inventory for adolescents: the QOLIE-AD-48. Epilepsia 40:1114-1121.
41. Crowley JS. (2003) Managing epilepsy care: Center for Health Services Research and Policy, School of Public Health, George Washington University Medical Center. 〈http://www.gwhealthpolicy.org/newsps/epilepsy/Managing epilepsy care.pdf〉.
42. Cunningham PJ, May JH. (2006) A growing hole in the safety net: center for studying health system change tracking report No. 13. 〈http://hschange. org/CONTENT/826/?topic=topic02〉.
43. Dell JL. (1986) Social dimensions of epilepsy: stigma and response. In-Whitman S, Hermann BP (Eds) Psychopathology in epilepsy. Oxford University Press, New York, pp. 185-210.
44. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. (1996) A prospective population-based epidemiological study of status epilepticus in Richmond, Virginia. Neurology 46:1029-1035.
45. DiIorio C, Shafer PO, Letz R, Henry T, Schomer DL, Yeager K. (2003) The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy and Behavior 4:259-267.
46. Devinsky O, Westbrook L, Cramer J, Glassman M, Perrinek D, Camfield C. (1999) Risk factors for poor health related quality of life in adolescents with epilepsy. Epilepsia 40:1715-1720.
47. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S. (2003) Detection of human herpesvirus 6 (HHV-6) in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:1405-1411.
48. Donner EJ, Smith CR, Snead OC 3rd. (2001) Sudden unexplained death in children with epilepsy. Neurology 57:430-434.
49. Ferris TG, Chang Y, Blumenthal D, Pearson SD. (2001) Leaving gate-keeping behind: effects of opening access to specialists for adults in a health maintenance organization. New England Journal of Medicine 345:1312-1317.
50. Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, Scherer A, Walker SG. (2000a) The impact of epilepsy from the patient's perspective, I: descriptions and subjective perceptions. Epilepsy Research 41:39-51.
51. Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, Scherer A, Walker SG. (2000b) The impact of epilepsy from the patient's perspective, II: views about therapy and health care. Epilepsy Research 41:53-61.
52. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology: Quality Standards Subcommittee of the American Academy of Neurology: American Epilepsy Society. (2004) Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy. Neurology 62:1261-1273.
53. Gajjar, M. Geva E, Humphries T, Peterson-Badali M, Otsubo H. (2000) A new scale to assess culture-specific beliefs and attitudes about epilepsy. Epilepsy and Behavior 1:235-255.
54. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM. (2004) Pharmacy benefits and the use of drugs by the chronically ill. Journal of the American Medical Association 291:2344-2350.
55. Gomez JG, Arciniegas E, Torres J. (1978) Prevalence of epilepsy in Bogota, Colombia. Neurology 28:90-95.
56. Greenlund KJ, Giles WH, Keenan NL, Croft JB, Mensah GA. (2002) Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise. Stroke 33:565-570.
57. Gross CP, Anderson FG, Powe NR. (1999) The relation between funding by the National Institutes of Health and the burden of disease. New England Journal of Medicine 340:1881-1887.
58. Gudmundsson G. (1963) Epilepsy in Iceland: a clinical and epidemiologic investigation. Acta Neurologica Scandinavica 43(suppl 25):1-124.
59. Haerer AF, Anderson DW, Schoenberg BS. (1986) Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 27:66-75.
60. Harden CL, Kossoy A, Vera S, Nikolov B. (2004) Reaction to epilepsy in the workplace. Epilepsia 45:1134-1140.
61. Hauser WA, Annegers JF, Elveback LR. (1980) Mortality in patients with epilepsy. Epilepsia 21:399-412.
62. Hauser WA, Annegers JF, Kurland LT. (1991) Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 32:429-445.
63. Hauser WA, Annegers JF, Kurland JT. (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34:453-468.
64. Health Resources and Services Administration. (2004) HRSA awards $2.9 million to improve health care for children with epilepsy. 〈http://newsroom.hrsa.gov/releases/2004/epilepsy.htm〉.
65. Hirota S, Garcia J, Silber R, Lamirault I, Penserga LJ, Hall MB. (2006) Inclusion of immigrant families in US: health coverage expansions. Journal of Health Care for the Poor Underserved 17:81-94.
66. Hodgson TA. (1988) Annual costs of illness versus lifetime costs of illness and implications of structural change. Drug Information Journal 22:323-341.
67. Hoffman C, Rice DP, Sung HY. (1996) Persons with chronic conditions: their prevalence and costs. Journal of the American Medical Association 176:1473-1479.
68. Huang ZJ, Yu SM, Ledsky R. (2006) Health status and health service access and use among children in U.S. immigrant families. American Journal of Public Health. Feb 28; [Epub ahead of print]
69. Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, Epstein A. (2004) How does the quality of care compare in five countries? Health Affairs 23:89-99.
70. Jacobs MP, Fischbach GD, Davis MR, Dichter MA, Dinledire R, Lowenstein D, Morrell MJ, Noebels JL, Rogawski MA, Spencer SS, Theodore WH. (2001) Future directions for epilepsy research. Neurology 57:1536-1542.
71. Jacoby A, Gorry J, Bamble C, Baker GA. (2004) Public knowledge, private grief: a study of public attitudes to epilepsy in the United Kingdom and implications for stigma. Epilepsia 45:1405-1415.
72. Jacoby A, Snape D, Baker GA. (2005) Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurology 4:17-78.
73. Jerath BK, Kimbell BA. (1981) Hospitalization rates for epilepsy in the United States, 1973-1976. Epilepsia 22:55-64.
74. Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. (2003) Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behavior Supplement 4:S31-S38.
75. Kaiser Commission on Medicaid and the Uninsured. (2004) The uninsured: a primer. 〈http://www.kff.org/about/kcmu.cfm〉.
76. Kaiser Family Foundation. (2005) Women and health care: a national profile. 〈http://www.kff.org/womenshealth/whp070705pkg.cfm〉.
77. Keyhani S, Diener-West M, Powe N. (2005) Do drug prices reflect development time and government investment? Medical Care 43:753-762.
78. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. (2002) Diabetes Prevention Program Research Group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346:393-403.
79. Kobau R, DiIorio A, Prince PH, Thurman DJ, Martin LM, Ridings DL, Henry TR. (2004) Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: behavioral risk factor surveillance system, 2002. Epilepsy and Behavior 5:358-366.
80. Kobau R, DiIorio CA, Anderson LA, Price PH. (2006) Further validation and reliability testing of the attitudes and beliefs about living with epilepsy (ABLE) components of the CDC Epilepsy Program Instrument on Stigma. Epilepsy & Behavior 8:852-859.
81. Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA. (2002) Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 43:1402-1409.
82. Kozyrskyj AL, Prasad AN. (2004) The burden of seizures in Manitoba children: a population-based study. Canadian Journal of Neurological Science 31:45-83.
83. Lee TH, Zapert K. (2005) Do high-deductible health plans threaten quality of care? New England Journal of Medicine 353:1202-1204.
84. Lenzer J. (2004) Pfizer pleads guilty, but drug sales continue to soar. British Medical Journal 328:1217.
85. Living well with epilepsy II. (2004) Report of the 2003 National Conference. Priorities for a public health agenda on epilepsy. Epilepsy Foundation, Landover, Md. 2004.
86. McKinnell H. (2004) A battle that must be won. 〈http://www. globalagendamagazine.com/2004/henrymckinnell.asp〉.
87. Miller AM, Sorokin O, Wang E, Feetham S, Choi M, Wilbur J. (2006) Acculturation, social alienation, and depressed mood in midlife women from the former Soviet Union. Research in Nursing and Health 29:134-146.
88. Murphy CC, Trevathan E, Yeargin-Allsopp M. (1995) Prevalence of epilepsy and epileptic seizures in 10-year-old children: results from the metropolitan Atlanta developmental disabilities study. Epilepsia 36:866-872.
89. National Center for Health Care Statistics. (1994) National Hospital Discharge Survey: annual summary, 1992. US Department of Health and Human Services, Public Health Service, CDC, Hyattsville, Maryland, (Vital and health statistics; series 13, no. 119).
90. National Center for Chronic Disease Prevention and Health Promotion. (2005)A public health action plan to prevent heart disease and stroke. 〈http://www.cdc.gov/cvh/Action Plan/index.htm〉.
91. Newacheck PW, Stoddard JJ, Hughes DC, Pearl M. (1998) Health insurance and access to primary care for children. New England Journal of Medicine 338:513-519.
92. Osuntokun BO, Adeuja AO, Schoenberg BS, Bademosi O, Nottidge VA, Olumide AO. (1987) Neurological disorders in Nigerian Africans: a community-based study. Acta Neurologica Scandinavica 75:13-21.
93. Pear R. (2004) Academy of sciences calls for universal health care by 2010. NY Times Jan 15, 2004.
94. Population Reference Bureau. (2005) Analysis of the Census Bureau's U.S. Interim Population Projections. 〈www.census.gov/ipc/www/ usinterimproj〉.
95. Privitera M. (2006) Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Epilepsy Research 68:52-56.
96. Randel L, Pearson SD, Sabin JE, Hyams T, Emanuel EJ. (2001) How managed care can be ethical. Health Affairs 20:43-56.
97. Regalado A. (2004) Bush faces challenge from scientists. Wall Street Journal July 15, 2004, A4.
98. Richardson LP, DiGuiseppe D, Garrison M, Christakis DA. (2003) Depression in Medicaid-covered youth. Archives of Pediatric and Adolescent Medicine 157:984-989.
99. Roubideaux Y. (2005) Beyond Red Lake: the persistent crisis in American Indian health care. New England Journal of Medicine 353:1881-1883.
100. Ronen GM, Penney S, Andrews W. (1999) The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. Journal of Pediatrics 134:71-75.
101. Roper Organization. (1992) Living with epilepsy: report of a Roper poll of patients on quality of life. New York Growth from knowledge.
102. Rubenstein L, Pugh J. (2006) Strategies for promoting organizational and practice change by advocating implementation research. Journal of General Internal Medicine 21:58-64.
103. Stark N, Paskett E, Bell R, Cooper R, Walker E, Wilson A, Tatum C. (2002) Increasing participation of minorities in cancer clinical trials. Journal of the National Medical Association 94:31.
104. Schoen C, Osborn R, Huynh PT, Doty D, Zapert K, Peugh J, Davis K. (2005) Taking the pulse of health care systems: experiences of patients with health problems in six countries. Health Affairs W 5:509-525.
105. Shamansky SL, Glaser GH. (1979) Socioeconomic characteristics of childhood seizure disorders in the New Haven area: an epidemiological study. Epilepsia 20:457-474.
106. Shorvon SD. (2001) Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term prospective, population-based cohort. Annals of Neurology 49:336-344.
107. Sirven JI, Lopez RA, Vazquez B, Van Haverbeke P. (2005) Qué es la Epilepsia? Attitudes and knowledge of epilepsy by Spanish-speaking adults in the United States. Epilepsy & Behavior 7:259-265.
108. Snodgrass SR, Vedanarayanan VV, Parker CC, Parks BR. (2001) Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients. Journal of Child Neurology 16:164-168.
109. Soumerai SB. (2004) Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs 135-146.
110. Statistics Canada. (2002) National Population Health Survey-cycle 4 (2002-2001). 〈http://www.stats.gov.nt.ca/Statinfo/Health/NPHS/NPHS1. html〉.
111. Steinbrook R. (2005)Wall Street and clinical trials. New England Journal of Medicine 353:1091-1093.
112. Stossel TP. (2005) Regulating academic-industrial research relationships: solving problems or stifling progress? New England Journal Medicine 353:1060-1065.
113. Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D. (2003) Central challenges facing the national clinical research enterprise. Journal of the American Medical Association 289:1278-1287.
114. Swartztrauber K. (2001) Neurologists 2000: AAN member demographic and practice characteristics. American Academy of Neurology, St. Paul.
115. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, Wiebe S. (2004) National and regional prevalence of self-reported epilepsy in Canada. Epilepsia 45:1623-1629.
116. Tennis P, Cole TB, Annegers JF, Leestma JE, McNutt M, Rajput A. (1995) Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia 36:29-36.
117. Titlow K, Randel L, Clancy CM, Emanuel EJ. (2000) Drug coverage decisions: the role of dollars and values. Health Affairs 19:240-247.
118. Trevathan E. (2003) Antiepileptic drug development for "therapeutic orphans." Epilepsia 44(suppl 7):19-25.
119. Trimble MR, Dodson WE (Eds). (1994) Epilepsy and quality of life. Raven Press, New York.
120. U.S. Centers for Medicare and Medicaid Services. (2006) Health spending projections through 2015. 〈www.cms.hhs.gov/NationalHealthExpendData/ 03_NationalHealthAccountsProjected.asp〉.
121. U.S. Department of Health and Human Services. (2004) National Diabetes Action plan. 〈http://www.os.dhhs.gov/news/press/2004pres/NDAP04.pdf〉..
122. Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, Sander JW. (2003) The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 60:1544-1545.
123. Weissman JS, Betancourt J, Campbell EG, Park ER, Kim M, Clarridge B, Blumethal D, Lee KC, Maina AW. (2005) Resident physicans' preparedness to provide cross-cultural care. Journal of the American Medical Association 294:1058-1067.
124. Westbrook LE, Baumann LJ, Shinnar S. (1992) Applying stigma theory to epilepsy: a test of a conceptual model. Journal of Pediatric Psychology 17:633-649.
125. Wiebe S, Belhouse D, Fallahay C, Eliasziw M. (1999) Burden of epilepsy: the Ontario Health Survey. Canadian Journal of Neurological Science 26:263-270.
126. Woolf SH, Johnson RE, Fryer GE Jr, Rust G, Satcher D. (2004) The health impact of resolving racial disparities: an analysis of US mortality data. American Journal of Public Health 94:2078-2081.
127. Woolf SH, Johnson RE. (2005) The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Annals of Family Medicine 3:545-552.
128. World Health Organization. (2003) Caring for children and adolescents with mental disorders. Geneva. 〈http://www.who.int/mental_health/media/en/ 785.pdf〉.